Abstract
17β-estradiol (E2), as the main circulating estrogen hormone, plays critical roles in the physiology and pathophysiology of various tissues. The E2 information is primarily conveyed by the transcription factors, estrogen receptors (ERs) α and β. ERs share similar structural and functional features. Experimental studies indicate that upon binding to E2, ERs directly or indirectly interact with DNA and regulate gene expressions with ERα being more potent transregulator than ERβ. However, studies also showed that ERβ induces alterations in phenotypic features of cancer cell lines independent of E2. These observations suggested that the manner in which the unliganded ERβ induces phenotypic alterations in cancer cell models differs from that of ERα. Studies demonstrated that while requiring E2 for function at low levels of synthesis, the unliganded ERα at augmented concentrations modulates gene expressions and cellular growth. We, therefore, anticipated that heightened levels of ERβ synthesis could similarly circumvent the dependency on E2 leading to gene transcriptions and cellular proliferation. To test this prediction, we used adenovirus-infected cancer cell lines in which ERs were shown to induce genomic and cellular responses. We found that while ERβ at low levels of synthesis was dependent upon E2 for function, the receptor at high levels regulated gene expression and cellular proliferation independent of E2. We then addressed whether ERs at comparable levels that require E2 for function differentially alter gene expressions and cellular responses. We found that ERs mediate the effects of E2 on gene expression, cellular proliferation, apoptosis, and motility with an overlapping pattern. However, ERα was more potent regulator than ERβ in inducing cellular responses. Our results suggest that differences in potencies to regulate the expression of genes are a critical feature of the ER subtypes in mediating E2 signaling in cancer cell lines.
Similar content being viewed by others
References
J. Huang, X. Li, R. Hilf, R.A. Bambara, M. Muyan, Curr. Drug Targets Immune Endocr. Metabol. Disord. 5, 379–396 (2005)
B.J. Deroo, K.S. Korach, J. Clin. Invest. 116, 561–570 (2006)
J.M. Hall, J.F. Couse, K.S. Korach, J. Biol. Chem. 276, 36869–36872 (2001)
P.J. Kushner, D.A. Agard, G.L. Greene, T.S. Scanlan, A.K. Shiau, R.M. Uht, P. Webb, J. Steroid Biochem. Mol. Biol. 74, 311–317 (2000)
S. Safe, Vitam. Horm. 62, 231–252 (2001)
M. Soulez, M.G. Parker, J. Mol. Endocrinol. 27, 259–274 (2001)
J. Frasor, J.M. Danes, B. Komm, K.C. Chang, C.R. Lyttle, B.S. Katzenellenbogen, Endocrinology 144, 4562–4574 (2003)
A. Licznar, S. Caporali, A. Lucas, A. Weisz, F. Vignon, G. Lazennec, FEBS Lett. 553, 445–450 (2003)
J.G. Moggs, T.C. Murphy, F.L. Lim, D.J. Moore, R. Stuckey, K. Antrobus, I. Kimber, G. Orphanides, J. Mol. Endocrinol. 34, 535–551 (2005)
E.C. Chang, J. Frasor, B. Komm, B.S. Katzenellenbogen, Endocrinology 147, 4831–4842 (2006)
G. Lazennec, D. Bresson, A. Lucas, C. Chauveau, F. Vignon, Endocrinology 142, 4120–4130 (2001)
D.A. Tonetti, R. Rubenstein, M. DeLeon, H. Zhao, S.G. Pappas, D.J. Bentrem, B. Chen, A. Constantinou, V. Craig Jordan, J. Steroid Biochem. Mol. Biol. 87, 47–55 (2003)
J. Cheng, E.J. Lee, L.D. Madison, G. Lazennec, FEBS Lett. 566, 169–172 (2004)
Y.F. Hou, S.T. Yuan, H.C. Li, J. Wu, J.S. Lu, G. Liu, L.J. Lu, Z.Z. Shen, J. Ding, Z.M. Shao, Oncogene 23, 5799–5806 (2004)
S. Paruthiyil, H. Parmar, V. Kerekatte, G.R. Cunha, G.L. Firestone, D.C. Leitman, Cancer Res. 64, 423–428 (2004)
F. Stossi, D.H. Barnett, J. Frasor, B. Komm, C.R. Lyttle, B.S. Katzenellenbogen, Endocrinology 145, 3473–3486 (2004)
V. Martineti, L. Picariello, I. Tognarini, S. Carbonell Sala, A. Gozzini, C. Azzari, C. Mavilia, A. Tanini, A. Falchetti, G. Fiorelli, F. Tonelli, M.L. Brandi, Endocr. Relat. Cancer 12, 455–469 (2005)
D.G. Monroe, F.J. Secreto, M. Subramaniam, B.J. Getz, S. Khosla, T.C. Spelsberg, Mol. Endocrinol. 19, 1555–1568 (2005)
A. Bardin, N. Boulle, G. Lazennec, F. Vignon, P. Pujol, Endocr. Relat. Cancer 11, 537–551 (2004)
X. Li, S.L. Nott, Y. Huang, R. Hilf, R.A. Bambara, X. Qiu, A. Yakovlev, S. Welle, M. Muyan, J. Mol. Endocrinol. 40, 211–229 (2008)
S.L. Nott, Y. Huang, X. Li, B.R. Fluharty, X. Qiu, W.V. Welshons, S. Yeh, M. Muyan, J. Biol. Chem. 284, 15277–15288 (2009)
A.M. Fowler, N. Solodin, M.T. Preisler-Mashek, P. Zhang, A.V. Lee, E.T. Alarid, FASEB J. 18, 81–93 (2004)
A.M. Fowler, N.M. Solodin, C.C. Valley, E.T. Alarid, Mol. Endocrinol. 20, 291–301 (2006)
M. Garcia, D. Derocq, G. Freiss, H. Rochefort, Proc. Natl. Acad. Sci. U S A 89, 11538–11542 (1992)
S.Y. Jiang, V.C. Jordan, J. Natl. Cancer Inst. 84, 580–591 (1992)
D.A. Zajchowski, R. Sager, L. Webster, Cancer Res. 53, 5004–5011 (1993)
M. Wang, H. Dotzlaw, S.A. Fuqua, L.C. Murphy, Breast Cancer Res. Treat. 44, 145–151 (1997)
A.S. Levenson, V.C. Jordan, J. Steroid Biochem. Mol. Biol. 51, 229–239 (1994)
G. Lazennec, J.L. Alcorn, B.S. Katzenellenbogen, Mol. Endocrinol. 13, 969–980 (1999)
G. Lazennec, B.S. Katzenellenbogen, Mol. Cell. Endocrinol. 149, 93–105 (1999)
A. Barron-Gonzalez, I. Castro Romero, Biochem. Cell Biol. 82, 335–342 (2004)
M. Kian Tee, I. Rogatsky, C. Tzagarakis-Foster, A. Cvoro, J. An, R.J. Christy, K.R. Yamamoto, D.C. Leitman, Mol. Biol. Cell 15, 1262–1272 (2004)
J. Huang, X. Li, C.A. Maguire, R. Hilf, R.A. Bambara, M. Muyan, Mol. Endocrinol. 19, 2696–2712 (2005)
W. Gorczyca, M.R. Melamed, Z. Darzynkiewicz, Methods Mol. Biol. 91, 217–238 (1998)
M. Garcia, D. Derocq, N. Platet, S. Bonnet, J.P. Brouillet, I. Touitou, H. Rochefort, J. Steroid Biochem. Mol. Biol. 61, 11–17 (1997)
A.M. Brzozowski, A.C. Pike, Z. Dauter, R.E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G.L. Greene, J.A. Gustafsson, M. Carlquist, Nature 389, 753–758 (1997)
A.C. Pike, A.M. Brzozowski, R.E. Hubbard, T. Bonn, A.G. Thorsell, O. Engstrom, J. Ljunggren, J.A. Gustafsson, M. Carlquist, EMBO J. 18, 4608–4618 (1999)
J.M. Wurtz, W. Bourguet, J.P. Renaud, V. Vivat, P. Chambon, D. Moras, H. Gronemeyer, Nat. Struct. Biol. 3, 87–94 (1996)
D.M. Tanenbaum, Y. Wang, S.P. Williams, P.B. Sigler, Proc. Natl. Acad. Sci. U S A 95, 5998–6003 (1998)
A.C. Pike, Best Pract. Res. Clin. Endocrinol. Metab. 20, 1–14 (2006)
P. Yi, M.D. Driscoll, J. Huang, S. Bhagat, R. Hilf, R.A. Bambara, M. Muyan, Mol. Endocrinol. 16, 674–693 (2002)
A. Tamrazi, K.E. Carlson, A.L. Rodriguez, J.A. Katzenellenbogen, Mol. Endocrinol. 19, 1516–1528 (2005)
A. Tamrazi, K.E. Carlson, J.R. Daniels, K.M. Hurth, J.A. Katzenellenbogen, Mol. Endocrinol. 16, 2706–2719 (2002)
Y. Bai, V. Giguere, Mol. Endocrinol. 17, 589–599 (2003)
H.W. Chen, R.J. Lin, W. Xie, D. Wilpitz, R.M. Evans, Cell 98, 675–686 (1999)
Y. Shang, X. Hu, J. DiRenzo, M.A. Lazar, M. Brown, Cell 103, 843–852 (2000)
R. Metivier, G. Penot, M.R. Hubner, G. Reid, H. Brand, M. Kos, F. Gannon, Cell 115, 751–763 (2003)
G. Reid, M.R. Hubner, R. Metivier, H. Brand, S. Denger, D. Manu, J. Beaudouin, J. Ellenberg, F. Gannon, Mol. Cell 11, 695–707 (2003)
R. Metivier, G. Penot, R.P. Carmouche, M.R. Hubner, G. Reid, S. Denger, D. Manu, H. Brand, M. Kos, V. Benes, F. Gannon, EMBO J. 23, 3653–3666 (2004)
D. Dubik, R.P. Shiu, Oncogene 7, 1587–1594 (1992)
F. Baehner, L. Habel, C. Quesenberry, A. Capra, G. Tang, S. Paik, N. Wolmark, D. Watson, S. Shak, Breast Cancer Res. Treat. 100, S21 (2006)
S. Lopez-Tarruella, R. Schiff, Clin. Cancer Res. 13, 6921–6925 (2007)
O.W. Prall, E.M. Rogan, R.L. Sutherland, J. Steroid Biochem. Mol. Biol. 65, 169–174 (1998)
H. Rochefort, N. Platet, Y. Hayashido, D. Derocq, A. Lucas, S. Cunat, M. Garcia, J. Steroid Biochem. Mol. Biol. 65, 163–168 (1998)
N. Platet, A.M. Cathiard, M. Gleizes, M. Garcia, Crit. Rev. Oncol. Hematol. 51, 55–67 (2004)
S.M. Cowley, M.G. Parker, J. Steroid Biochem. Mol. Biol. 69, 165–175 (1999)
E.M. McInerney, K.E. Weis, J. Sun, S. Mosselman, B.S. Katzenellenbogen, Endocrinology 139, 4513–4522 (1998)
J.M. Hall, D.P. McDonnell, Endocrinology 140, 5566–5578 (1999)
F. Delaunay, K. Pettersson, M. Tujague, J.A. Gustafsson, Mol. Pharmacol. 58, 584–590 (2000)
P. Yi, S. Bhagat, R. Hilf, R.A. Bambara, M. Muyan, Mol. Endocrinol. 16, 1810–1827 (2002)
X. Li, J. Huang, P. Yi, R.A. Bambara, R. Hilf, M. Muyan, Mol. Cell. Biol. 24, 7681–7694 (2004)
J. Huang, X. Li, T. Qiao, R.A. Bambara, R. Hilf, M. Muyan, Nucl Recept Signal 4, e015 (2006)
X. Li, J. Huang, B.R. Fluharty, Y. Huang, S.L. Nott, M. Muyan, J. Steroid Biochem. Mol. Biol. 109, 266–272 (2008)
J.M. Beekman, G.F. Allan, S.Y. Tsai, M.J. Tsai, B.W. O’Malley, Mol. Endocrinol. 7, 1266–1274 (1993)
W.L. Kraus, E.M. McInerney, B.S. Katzenellenbogen, Proc. Natl. Acad. Sci. U S A 92, 12314–12318 (1995)
L. Tora, J. White, C. Brou, D. Tasset, N. Webster, E. Scheer, P. Chambon, Cell 59, 477–487 (1989)
M.T. Tzukerman, A. Esty, D. Santiso-Mere, P. Danielian, M.G. Parker, R.B. Stein, J.W. Pike, D.P. McDonnell, Mol. Endocrinol. 8, 21–30 (1994)
E.M. McInerney, M.J. Tsai, B.W. O’Malley, B.S. Katzenellenbogen, Proc. Natl. Acad. Sci. U S A 93, 10069–10073 (1996)
P. Webb, P. Nguyen, J. Shinsako, C. Anderson, W. Feng, M.P. Nguyen, D. Chen, S.M. Huang, S. Subramanian, E. McKinerney, B.S. Katzenellenbogen, M.R. Stallcup, P.J. Kushner, Mol. Endocrinol. 12, 1605–1618 (1998)
P. Zhu, S.H. Baek, E.M. Bourk, K.A. Ohgi, I. Garcia-Bassets, H. Sanjo, S. Akira, P.F. Kotol, C.K. Glass, M.G. Rosenfeld, D.W. Rose, Cell 124, 615–629 (2006)
A. Benecke, P. Chambon, H. Gronemeyer, EMBO Rep. 1, 151–157 (2000)
R.M. Uht, P. Webb, P. Nguyen, R.H. Price Jr., C. Valentine Jr., H. Favre, P.J. Kushner, Nucl Recept. 2, 2 (2004)
J.R. Schultz, L.N. Petz, A.M. Nardulli, J. Biol. Chem. 280, 347–354 (2005)
B. Saville, M. Wormke, F. Wang, T. Nguyen, E. Enmark, G. Kuiper, J.A. Gustafsson, S. Safe, J. Biol. Chem. 275, 5379–5387 (2000)
K. Kim, N. Thu, B. Saville, S. Safe, Mol. Endocrinol. 17, 804–817 (2003)
M. Muyan, P. Yi, G. Sathya, L.J. Willmert, M.D. Driscoll, R. Hilf, R.A. Bambara, Mol. Cell. Endocrinol. 182, 249–263 (2001)
K.J. Livak, T.D. Schmittgen, Methods 25, 402–408 (2001)
Acknowledgment
We thank Michelle Zanche and Meghann McBennett of the Functional Genomic Center at the University of Rochester for the incessant guidance, assistance, and execution of qPCR. We are also grateful to Dr. Tim Bushnell and Matthew Cochran of the Cell Separation and Flow Cytometry Facility of the University of Rochester for the supervision and assistance for FACS studies. We thank Mark Gallagher for the critical reading of the manuscript. This study was supported by NIH CA113682 (MM).
Conflict of interest
The authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, Y., Li, X. & Muyan, M. Estrogen receptors similarly mediate the effects of 17β-estradiol on cellular responses but differ in their potencies. Endocr 39, 48–61 (2011). https://doi.org/10.1007/s12020-010-9411-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-010-9411-8